This information was published on 2024-10-30T00:03:23 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2454068 |
| (220) |
29 May 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations, namely, anti-psychotics |
| (540) | WELTRUZA |
| (550) | Word |
| (730) |
Teva Pharmaceuticals International GmbH
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.